Paradoxical Antidiabetogenic Effect of γ-Interferon in DP-BB Rats
Ferdinando Nicoletti(University of Catania), Gianni Garotta(Roche (Switzerland)), L Mughini(University of Milan), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Paola Zaccone(University of Catania), Giliola Calori(University of Milan), Roberto Di Marco(University of Catania), Franca Stivala(University of Catania), Sebastiano Grasso(University of Catania), Gaetano Magro(University of Catania)
Cited by 37
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508